Compare RECT & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RECT | NAII |
|---|---|---|
| Founded | 1997 | 1980 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.1M | 21.2M |
| IPO Year | 2024 | 1987 |
| Metric | RECT | NAII |
|---|---|---|
| Price | $1.70 | $4.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.7K | ★ 16.1K |
| Earning Date | 02-20-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | $32,594,177.00 | ★ $134,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.52 | ★ N/A |
| Revenue Growth | 5.91 | ★ 19.00 |
| 52 Week Low | $1.50 | $2.57 |
| 52 Week High | $7.26 | $4.31 |
| Indicator | RECT | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 39.54 | 80.20 |
| Support Level | $1.59 | $3.14 |
| Resistance Level | $1.97 | $3.55 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 42.55 | 87.66 |
Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.